We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+8.15%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$287B
AUM Growth
+$27.6B
Cap. Flow
+$6.59B
Cap. Flow %
2.29%
Top 10 Hldgs %
12.98%
Holding
8,864
New
808
Increased
4,307
Reduced
2,684
Closed
688

Sector Composition

Rank Sector Weight
1 Technology 9.82%
2 Financials 7.38%
3 Healthcare 6.65%
4 Consumer Discretionary 5.46%
5 Industrials 5.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BGS icon
1776
B&G Foods
BGS
$289M
$12.1M ﹤0.01%
676,453
-133,987
-17% -$2.25M
ETFC
1777
PUT
DELISTED
E*Trade Financial Corporation
ETFC
$12.1M ﹤0.01%
+267,300
New +$11.4M
PBCT
1778
DELISTED
People's United Financial Inc
PBCT
$12.1M ﹤0.01%
716,992
-145,475
-17% -$2.38M
SKT icon
1779
Tanger
SKT
$4.68B
$12.1M ﹤0.01%
822,123
-8,171
-1% -$128K
IMCV icon
1780
iShares Morningstar Mid-Cap Value ETF
IMCV
$1.16B
$12.1M ﹤0.01%
215,127
+3,318
+2% +$180K
VLO icon
1781
CALL
Valero Energy
VLO
$88.9B
$12.1M ﹤0.01%
129,100
+70,400
+120% +$6.65M
LIVN icon
1782
LivaNova
LIVN
$4.69B
$12.1M ﹤0.01%
160,227
+53,488
+50% +$4.06M
KTB icon
1783
Kontoor Brands
KTB
$4.61B
$12.1M ﹤0.01%
287,723
+22,129
+8% +$836K
HRL icon
1784
Hormel Foods
HRL
$13.9B
$12.1M ﹤0.01%
267,807
+5,966
+2% +$257K
SPXX icon
1785
Nuveen S&P 500 Dynamic Overwrite Fund
SPXX
$341M
$12.1M ﹤0.01%
733,162
+43,057
+6% +$684K
BBD icon
1786
Banco Bradesco
BBD
$37.9B
$12.1M ﹤0.01%
1,794,152
+608,594
+51% +$3.81M
EXG icon
1787
Eaton Vance Tax-Managed Global Diversified Equity Income Fund
EXG
$3.04B
$12M ﹤0.01%
1,371,446
+147,156
+12% +$1.25M
SCHE icon
1788
Schwab Emerging Markets Equity ETF
SCHE
$12.8B
$12M ﹤0.01%
439,935
+11,219
+3% +$296K
HELE icon
1789
Helen of Troy
HELE
$658M
$12M ﹤0.01%
66,870
+33,517
+100% +$5.38M
WU icon
1790
Western Union
WU
$2.28B
$12M ﹤0.01%
448,225
-36,878
-8% -$956K
J icon
1791
Jacobs Solutions
J
$16.8B
$12M ﹤0.01%
161,527
+35,787
+28% +$2.71M
GWPH
1792
CALL
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$12M ﹤0.01%
114,700
+90,000
+364% +$10.1M
CRI icon
1793
Carter's
CRI
$1.46B
$12M ﹤0.01%
109,654
+16,589
+18% +$1.68M
NVCR icon
1794
NovoCure
NVCR
$1.89B
$12M ﹤0.01%
142,218
+62,517
+78% +$5.05M
PID icon
1795
Invesco International Dividend Achievers ETF
PID
$923M
$12M ﹤0.01%
702,198
+19,857
+3% +$325K
NBIS
1796
CALL
Nebius Group N.V.
NBIS
$57.3B
$11.9M ﹤0.01%
274,480
-556,420
-67% -$20.7M
OVV icon
1797
CALL
Ovintiv
OVV
$16.8B
$11.9M ﹤0.01%
508,580
CRL icon
1798
Charles River Laboratories
CRL
$11.3B
$11.9M ﹤0.01%
78,014
+43,182
+124% +$5.98M
HBI
1799
DELISTED
Hanesbrands
HBI
$11.9M ﹤0.01%
802,086
-2,121,355
-73% -$32.2M
XHE icon
1800
State Street SPDR S&P Health Care Equipment ETF
XHE
$165M
$11.9M ﹤0.01%
138,985
+1,597
+1% +$130K

Similar funds

UBS Group's Q4 2019 Portfolio in Review

As of Q4 2019, UBS Group held 8,864 positions worth $287B, up 11% from $260B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group's Q4 2019 filing shows 808 new, 4,307 increased, 2,684 reduced and 688 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.3B.

By sector, the portfolio is most concentrated in Technology at 9.8% of assets, up from 9.5% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M.
  • UBS Group added most to UBS Group in Q4 2019, an estimated $1.48B increase.
  • UBS Group's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.3B.
  • UBS Group fully exited Altaba Inc in Q4 2019, selling an estimated $759M.
  • UBS Group's ten largest holdings make up 13% of its $287B portfolio in Q4 2019.
  • UBS Group opened 808 new positions and closed 688 in Q4 2019.
  • UBS Group's portfolio value rose 11% quarter-over-quarter to $287B.

Based on UBS Group's 13F filing for Q4 2019, filed 14 Feb 2020.